A colorectal cancer (CRC) screening public health initiative launched in Harbin, China has attracted about 830,000 ...

Colorectal cancer (CRC ... supporting a polyclonal origin model. Researchers, utilizing a base editor-enabled DNA barcoding system, meticulously mapped the single-cell phylogenies in mouse ...

With high-sensitivity and strong negative predictive value, this artificial intelligence (AI)-powered tool enhances early colorectal cancer (CRC) detection and risk stratification in primary care.

Researchers may be one step closer to unravelling the cause of a colon cancer crisis in relatively young people. They've ...

Oxford Drug Design Ltd. has announced additional in vivo validation for its novel approach against cancer. The innovative approach, using generative AI capabilities, is based on the novel target ...

Colorectal cancer remains the third most common malignancy worldwide, with advanced stages presenting significant challenges for treatment. A recently published study highlights the potential of ...

Oxford Drug Design has reported positive results from an in vivo colorectal cancer model study on mice, which, it said, ...